Initial study on TMPRSS2 p.Val160Met genetic variant in COVID-19 patients

Initial study on TMPRSS2 p.Val160Met genetic variant in COVID-19 patients

Abstract Background Coronavirus disease 2019 (COVID-19) is a global health problem that causes millions of deaths worldwide. The clinical manifestation of COVID-19 widely varies from asymptomatic infection to severe pneumonia and systemic inflammatory disease. It is thought that host genetic variabi...

Täydet tiedot

Bibliografiset tiedot
Päätekijät: Laksmi Wulandari, Berliana Hamidah, Cennikon Pakpahan, Nevy Shinta Damayanti, Neneng Dewi Kurniati, Christophorus Oetama Adiatmaja, Monica Rizky Wigianita, Soedarsono, Dominicus Husada, Damayanti Tinduh, Cita Rosita Sigit Prakoeswa, Anang Endaryanto, Ni Nyoman Tri Puspaningsih, Yasuko Mori, Maria Inge Lusida, Kazufumi Shimizu, Delvac Oceandy
Aineistotyyppi: Artikkeli
Kieli:English
Julkaistu: BMC 2021-05-01
Sarja:Human Genomics
Aiheet:
COVID-19
TMPRSS2
Polymorphism
Linkit:https://doi.org/10.1186/s40246-021-00330-7

Internet

https://doi.org/10.1186/s40246-021-00330-7

Samankaltaisia teoksia